ALLIANCEBERNSTEIN L.P. - IDENIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of IDENIX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$5,098,000
+389.3%
211,520
+22.4%
0.00%
+300.0%
Q1 2014$1,042,000
-4.0%
172,820
-4.8%
0.00%0.0%
Q4 2013$1,085,000
+15.8%
181,520
+0.9%
0.00%0.0%
Q3 2013$937,000
+47.6%
179,869
+2.3%
0.00%0.0%
Q2 2013$635,000175,7910.00%
Other shareholders
IDENIX PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Baupost Group 29,665,693$153,965,0004.40%
Bain Capital Public Equity Management, LLC 12,664,950$65,731,0001.65%
BRIDGER MANAGEMENT, LLC 4,360,628$22,632,0001.62%
12 West Capital Management LP 1,782,100$9,249,0001.32%
GENERAL AMERICAN INVESTORS CO INC 858,979$4,458,0000.39%
BB BIOTECH AG 1,250,000$6,488,0000.35%
Aris Wealth Services, Inc. 30,000$156,0000.28%
ARROWGRASS CAPITAL PARTNERS (US) LP 800,400$4,154,0000.16%
Visium Asset Management, LP 1,307,132$6,810,0000.15%
Old West Investment Management, LLC 59,038$306,0000.15%
View complete list of IDENIX PHARMACEUTICALS INC shareholders